Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

@inproceedings{Aleskandarany2010PrognosticVO,
  title={Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer},
  author={Mohammed A. Aleskandarany and Andrew R. Green and Ahmed A. Benhasouna and Fabr{\'i}cio F. T. Barros and Keith R. Neal and Jorge S Reis-Filho and Ian O. Ellis and Emad A Rakha},
  booktitle={Breast Cancer Research},
  year={2010}
}
Although the prognostic significance of proliferation in early invasive breast cancer has been recognized for a long time, recent gene-expression profiling studies have reemphasized its biologic and prognostic value and the potential application of its assessment in routine practice, particularly to define prognostic subgroups of luminal/hormone receptor-positive (HR+) tumors. This study aimed to assess the prognostic value of a proliferation assay by using Ki-67 immunohistochemistry as… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 46 CITATIONS, ESTIMATED 63% COVERAGE

75 Citations

01020'11'13'15'17'19
Citations per Year
Semantic Scholar estimates that this publication has 75 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 37 REFERENCES

Similar Papers

Loading similar papers…